Breast Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts

 

Breast implants are types of prostheses used to change the size, contour, and shape of a person’s breast. Generally, in plastic surgery, breast implants can be placed to restore a natural-looking breast after mastectomy.

Increasing incidence of breast cancer is expected to drive growth of the global breast implants market during the forecast period. Breast cancer is one of the most common types of cancer among women, which requires surgical procedures. According to the World Cancer Research Fund (WCRF), in 2018, around 2 million new cases of breast cancer were recorded across the globe. According to the U.S. Breast Cancer Statistics, 1 in 8 U.S. women, around 12%, is expected to develop invasive breast cancer over the course of her lifetime. Through breast implants, surgeons can create a reconstructed breast after a mastectomy, which is the removal of natural breast tissue. Thus, these factors are expected to drive growth of the global breast implants market during the forecast period. Furthermore, increasing number of breast augmentation procedures is expected to drive growth of the global breast implants market growth over the forecast period. Besides, technological advancements are expected to boost the global breast implants market growth over the forecast period.

However, high cost of implantation procedure combined with the risk of complications is expected to hinder the global breast implants market growth over the forecast period. Moreover, the emergence of alternative techniques is expected to restrain the market growth in the near future. Among regions, North America is expected to witness significant growth in the global breast implants market during the forecast period. This is owing to rising healthcare expenditure in the U.S. Increasing prevalence of breast cancer is expected to boost the regional market growth over the forecast period. Moreover, Europe is expected to register a robust growth rate over the forecast period, owing to a high level of awareness regarding cosmetic surgeries in the region.

Key companies involved in the global breast implants market are Allergan plc, Sientra Inc., Establishment Labs SA, Shanghai Kangning Medical Supplies Ltd, GC Aesthetics, Polytech Health & Aesthetics GmbH, Groupe Sebbin SAS, Mentor Worldwide LLC, and Laboratories Arion.

For instance, in August 2020, Sientra Inc., a medical aesthetics company, received the approval from Pharmaceutical and Medical Device Agency (PDMA), Japan for the OPUS line of breast implants in Japan.